Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
View Patent ↗The invention discloses a composition comprising at least one N-acetyl lactosamine, at least one sialylated oligosaccharide and at least one fucosylated oligosaccharide, and a hydrolysate comprising partially and/or extensively hydrolyzed proteins, for use in the prevention and/or treatment of skin conditions and skin diseases. Preferably said composition is a starter infant formula. Said skin disease is in particular atopic dermatitis.
1. A method for treatment of atopic dermatitis by promoting metabolic activity and growth of lactic acid bacteria comprising Bifidobacterium longum subsp. infantis , the method comprising administering orally to an individual in need of same an effective amount of a composition consisting of carbohydrates, proteins comprising hydrolysed proteins in which 15% to 95% of the hydrolysed proteins have a molecular weight less than 1,000 Dalton, lipids, minerals, and vitamins, the carbohydrates comprising oligosaccharides consisting of (i) lacto-N-tetraose, 3′-sialyllactose, 6′-sialyllactose, 2′-fucosyllactose, and difucosyllactose, and the lacto-N-tetraose, the 3′-sialyllactose, the 6′-sialyllactose, the 2′-fucosyllactose, and the difucosyllactose are the only human oligosaccharides in the composition; or (ii) lacto-N-tetraose, lacto-N-neotetraose, 3′-sialyllactose, 6′-sialyllactose, 2′-fucosyllactose, and difucosyllactose, and the lacto-N-tetraose, the lacto-N-neotetraose, the 3′-sialyllactose, the 6′-sialyllactose, the 2′-fucosyllactose, and the difucosyllactose are the only human oligosaccharides in the composition, the individual is an infant with a food allergy or a young child with a food allergy.
2. The method of claim 1 , wherein the extent of hydrolysis of the hydrolysed proteins is between 50 and 100 of non-protein nitrogen/total nitrogen %.
3. The method of claim 1 , wherein a trinitrobenzenesulfonic acid reactive Nitrogen % amino (lysine) nitrogen/total nitrogen of the hydrolysed proteins is 8-15%.
4. The method of claim 1 , wherein the composition is selected from the group consisting of a starter infant formula, an infant formula, a follow-on formula, a baby food formula, an infant cereals formula and a growing-up milk.
5. The method of claim 1 , including the step of administering the composition to the infant with a food allergy or the young child with a food allergy before and/or during a weaning period.
6. The method of claim 1 , including the step of administering the composition to the infant with a food allergy or the young child with a food allergy to reduce the frequency and/or occurrence and/or severity and/or duration of the skin diseases.
7. The method of claim 1 , including the step of administering the composition to the infant with a food allergy or the young child with a food allergy to promote skin health and/or for use in the enhancement of the hydration of the skin and/or for use in the reduction of skin rash, roughness and/or dryness and/or for use in the enhancement of the oral tolerance to allergens.
8. A method for the treatment of atopic dermatitis and for the enhancement of oral tolerance to allergens by promoting metabolic activity and growth of lactic acid bacteria comprising Bifidobacterium longum subsp. infantis , the method comprising administering orally to an individual in need of same an effective amount of a synthetic nutritional composition consisting of carbohydrates, proteins in which 15% to 95% of the proteins have a molecular weight less than 1,000 Dalton, lipids, minerals, and vitamins, the carbohydrates comprising oligosaccharides consisting of (i) lacto-N-tetraose, 3′-sialyllactose, 6′-sialyllactose, 2′-fucosyllactose, and difucosyllactose, and the lacto-N-tetraose, the 3′-sialyllactose, the 6′-sialyllactose, the 2′-fucosyllactose, and the difucosyllactose are the only human oligosaccharides in the synthetic nutritional composition; or (ii) lacto-N-tetraose, lacto-N-neotetraose, 3′-sialyllactose, 6′-sialyllactose, 2′-fucosyllactose, and difucosyllactose, and the lacto-N-tetraose, the lacto-N-neotetraose, the 3′-sialyllactose, the 6′-sialyllactose, the 2′-fucosyllactose, and the difucosyllactose are the only human oligosaccharides in the synthetic nutritional composition, the individual is an infant with a food allergy or a young child with a food allergy.
9. The method of claim 1 , wherein the composition is a supplement.
10. The method of claim 1 , wherein the composition has a ratio of the 3′-sialyllactose to the 6′-sialyllactose between 5:1 and 1:2.
11. The method of claim 1 , wherein the administering of the effective amount of the composition to the infant with a food allergy or the young child with a food allergy comprises administering the composition before and during a weaning period.
12. The method of claim 1 , wherein the proteins are present in the composition in an amount less than 1.8 g per 100 kcal of the composition.